|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,640.00 JPY | +0.28% |
|
+0.14% | -5.83% |
| 02-06 | BML, Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026 | CI |
| 02-06 | BML, Inc. Reports Earnings Results for the Nine Months Ended December 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 838M | - | - | |||
| 38.87B | - | ||||
| 23.24B | |||||
| 7.55B | |||||
| 4.89B | - | - | |||
| 2.93B |
- Stock Market
- Stocks
- 4694 Stock
- Charts BML, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
